跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,008 条关于
“targeted protein degraders”
全部
24,008
临床试验
9,756
药物
2,060
机构
95
资讯
12,097
去年
PROTACs: A Promising New Class of Targeted Protein Degraders Set to Revolutionize Disease Treatment
去年
Nurix Therapeutics Advances Bexobrutideg Phase III Program and Expands Protein Degrader Pipeline
11个月前
Pinetree Therapeutics Secures $47 Million Series B to Advance Novel Protein Degraders for Drug-Resistant Cancers
11个月前
Frontier Medicines Unveils DCAF2 as Novel E3 Ligase for Targeted Protein Degradation in Cancer Treatment
去年
RDP Pharma and Singapore's EDDC Partner to Develop Protein Degrader Therapies for Autoimmune Diseases
2个月前
Nurix Therapeutics Pipeline Review: BTK Degraders and Targeted Protein Degradation Advance in B-Cell Malignancies
11个月前
Orum Therapeutics Strengthens Degrader-Antibody Conjugate Platform with Key Executive Appointment
27天前
Orum Therapeutics Announces U.S. FDA Clearance of IND for ORM-1153, a First-in-Class CD123-GSPT1 Degrader-Antibody Conjugate
去年
PROTAC Protein Degraders Enter Phase 3 Trials, Targeting 'Undruggable' Proteins
8个月前
Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Advance Degrader-Antibody Conjugate Platform
第 1 页，共 1210 页
上一页
下一页
